BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Hyundai Bioscience Positions XAFTY As Potential Ebola And Hantavirus Treatment Following Strong IC50 Findings

Ebola IC50 (0.125μM)—Strong inhibition at less than half the concentration of the clinically-tested COVID-19 (0.28μM). Clinical safety confi...

May 22, 2026 | News

KBP Biosciences Says Singapore Court Made No Fraud Finding In Ongoing Novo Nordisk Arbitration

KBP Biosciences Pte. Ltd. issued a statement addressing the decision by the Singapore Court of Appeal to maintain the temporary injunction against the Comp...

May 22, 2026 | News

CHEPLAPHARM Group Advances AI Ready Supply Chain Transformation Through TraceLink Network Integration

The German pharmaceutical company unifies its digital partner network, laying the foundation for AI-driven supply chain orchestration TraceLink, the world...

May 18, 2026 | News

SN BioScience Inc. Initiates Global Phase 1b/2 Trial Of SNB 101 In Extensive Stage Small Cell Lung Cancer

SN BioScience Inc., a clinical-stage biotechnology company based in South Korea, announced today that it has initiated the first patient dosing in its...

May 18, 2026 | News

Thermo Fisher Introduces Gibco CTS DynaXS Single Use Bioreactor For Scalable Cell Therapy Manufacturing

New Gibco™ CTS™ DynaXS™ Single Use Bioreactor supports flexible, cGMP-ready cell expansion from process development to clinical productio...

May 05, 2026 | News

WuXi Biologics Advances Chengdu Microbial Manufacturing Site Toward GMP Production

WuXi Biologics (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced the structural completion and k...

April 27, 2026 | News

WuXi Biologics Secures MFDS GMP Certification For Three Key Manufacturing Facilities

WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), announced that three of its manufacturin...

April 24, 2026 | News

Mabwell Secures JFDA GMP Compliance For Denosumab Biosimilars, Marking PIC S Milestone

Mabwell (688062.SH), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced that its wholly-owned subsidiary, T-m...

April 22, 2026 | News

Avantor Expands St Louis Quality Control Capabilities To Accelerate Biopharma Manufacturing

St. Louis site strengthens integrated support for biopharma manufacturing Avantor, Inc, a leading global provider of mission-critical products and ser...

April 20, 2026 | News

Matricelf And CiRA Foundation Partner To Advance Scalable iPSC Based Neural Tissue Manufacturing

Matricelf Ltd. (TASE: MTLF), a biotechnology company developing a novel autologous engineered neural tissue therapy for patients with spinal cord injury, a...

March 31, 2026 | News

WuXi XDC Reports Strong 2025 Growth Driven By Bioconjugate Leadership And Expanding Global Footprint

Revenue increased by 46.7% YoY to RMB 5,944 million Gross profit surged by 72.5% YoY to RMB 2,139 million, with its margin of 3...

March 25, 2026 | Company results

Akeso Reports Durable Long Term Survival Benefit Of Cadonilimab In Advanced Cervical Cancer

Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced that the latest long-term survival analysis data from the China pivotal registrational Phase II ...

March 06, 2026 | Report

PHCbi Launches LiCellGrow Cell Expansion System To Advance CGT Manufacturing Efficiency

PHC Corporation’s Biomedical Division (Head Office: Chiyoda-ku, Tokyo; President: Nobuaki Nakamura; hereinafter “PHCbi”), a global provid...

March 03, 2026 | News

Formosa Pharmaceuticals Signs Exclusive Licensing Agreement With Arrotex For APP13007 In Australia And New Zealand

Taiwan-based Formosa Pharmaceuticals ("Formosa", 6838.TW) announced that the company has entered into an exclusive licensing agreement with Arrotex Ph...

February 24, 2026 | News

Stay Connected